Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype
Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, Teunissen CE.. Neurology, 2020-08-11
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To evaluate sex differences in CSF biomarkers, taking the potential modifying role of clinical disease stage and APOE ε4 genotype into account. Method We included participants (n = 1,801) with probable Alzheimer disease (AD) dementia (n = 937), mild cognitive impairment (MCI; n = 437), and subjective cognitive decline (SCD; n = 427). Main outcomes were CSF β-amyloid 1-42 (Aβ 42 ), total tau (t-Tau), and tau phosphorylated at threonine 181 (p-Tau) levels. Age-corrected 3-way interactions between sex, disease stage (i.e., syndrome diagnosis at baseline), and APOE ε4 were tested with linear regression analyses for each outcome measure. In case of significant interactions ( p APOE ε4 genotype, including age as a covariate. Results Three-way interactions were significant for t-Tau ( p p 42 . In APOE ε4 carriers, women showed higher p-Tau concentrations than men in SCD (Cohen d [95% confidence interval]: t-Tau = 0.52 [0.19-0.84], p p = 0.004) and MCI (Cohen d [95% CI]: t-Tau = 0.54 [0.28-0.80], p p APOE ε4 noncarriers, women showed higher p-Tau concentrations in MCI (Cohen d [95% CI]: t-Tau = 0.49 [0.17-0.80], p = 0.002; p-Tau = 0.47 [0.16-0.78], p = 0.003) and AD dementia (Cohen d [95% CI]: t-Tau = 0.42 [0.19-0.65], p p = 0.002) but not in SCD. Conclusions Within APOE ε4 carriers, sex differences in CSF p-Tau are more evident in early disease stages, whereas for APOE ε4 noncarriers, sex differences are more evident in advanced disease stages. These findings suggest that the effect of APOE ε4 on sex differences in CSF biomarkers depends on disease stage in AD.
What this study adds
Evidence grade: Low
The record lists 1,801 participants. Among 1,801 people with subjective cognitive decline, mild cognitive impairment or Alzheimer dementia, women had higher spinal-fluid tau levels than men, but where this showed up depended on APOE ε4. In ε4 carriers the difference was clearest at the early stages (SCD and MCI); in non-carriers it appeared at MCI and dementia but not SCD.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Babapour Mofrad, R., Tijms, B. M., Scheltens, P., Barkhof, F., van der Flier, W. M., Sikkes, S. A. M., et al. (2020). Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype. Neurology. https://doi.org/10.1212/wnl.0000000000010629
Vancouver
Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, et al. Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype. Neurology. 2020. doi:10.1212/wnl.0000000000010629. PMID: 32788242.
BibTeX
@article{babapourmofrad2020-32788242,
author = {Babapour Mofrad, R. and Tijms, B. M. and Scheltens, P. and Barkhof, F. and van der Flier, W. M. and Sikkes, S. A. M. and Teunissen, C. E.},
title = {{Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype}},
journal = {Neurology},
year = {2020},
doi = {10.1212/wnl.0000000000010629},
pmid = {32788242},
url = {https://doi.org/10.1212/wnl.0000000000010629}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- In case of significant interactions ( p APOE ε4 genotype, including age as a covariate.
- Results Three-way interactions were significant for t-Tau ( p p 42 .
- These findings suggest that the effect of APOE ε4 on sex differences in CSF biomarkers depends on disease stage in AD.
Why it matters
Among 1,801 people with subjective cognitive decline, mild cognitive impairment or Alzheimer dementia, women had higher spinal-fluid tau levels than men, but where this showed up depended on APOE ε4. In ε4 carriers the difference was clearest at the early stages (SCD and MCI); in non-carriers it appeared at MCI and dementia but not SCD. This was a one-time comparison of groups, so it shows an association, not a cause, and it tests no treatment.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants1,801
- Evidence strengthLow
How this study scored 58/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,801 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 81 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.1 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 3 / 6 | Cited 7.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 11 other studies in this library |
| Still being cited | 2 / 4 | Cited 36 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Charlotte Elisabeth Teunissen: h-index 116 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32788242) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 58 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1212/wnl.0000000000010629
- PubMed: 32788242
- Original source →
- Free full text: n.neurology.org →
Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 21.
Later studies that cite this one
11 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Genetics from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.